Our aim is to strengthen Siegfried's standing and credibility in the public and to enhance long-term enterprise value. As our focus is on transparency, we disclose all relevant information to facilitate comprehensive assessment of the company.
There are many good reasons to invest in Siegfried:
- Siegfried is the global industry leading Custom Manufacturing Organization (API) and one of two important integrated partners of the pharma industry (Drug Substances and Drug Products).
- Critical size thanks to with 2300 employees generating sales of > CHF 500M
- Focus on core business and USP: one-stop-shop for primary and secondary manufacturing
- Globally efficient manufacturing (9 sites on 3 continents, incl. Asia)
- Alignment of business and asset strategy
- Broad technology base through acquisition and investments (new site in Nantong, high potency in Zofingen and Malta, spray drying in Pennsville)
- Solid cash flows in all businesses; working capital performance and expense control
- Variabilization of costs
- High "natural hedge" as a priority of risk management
- Sound financing structure with credit facility of a syndicate of Swiss banks
- Continuous growth, organic and through acquisition